Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright restated their buy rating on shares of RAPT Therapeutics (NASDAQ:RAPT – Get Rating) in a research note released on Tuesday, Benzinga reports. The brokerage currently has a $43.00 price target on the stock. HC Wainwright also issued estimates for RAPT Therapeutics’ Q1 2024 earnings at ($0.88) EPS, Q2 2024 earnings at ($0.91) EPS, […]
Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome raises $77.3M in funding.
AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, today announced the appointment
The Fintel Insider Sentiment quant model identifies US stocks that have experienced significant insider buying activity over the last 90 days.
Research analysts at The Goldman Sachs Group began coverage on shares of RAPT Therapeutics (NASDAQ:RAPT – Get Rating) in a research report issued to clients and investors on Thursday, The Fly reports. The firm set a “buy” rating and a $27.00 price target on the stock. The Goldman Sachs Group’s price target would indicate a […]